Elevated levels of soluble ST2 but not galectin-3 are associated with increased risk of mortality in hemodialysis patients
Background The soluble forms of suppression of tumorigenicity-2 (ST2) and galectin-3 have been proposed as novel biomarkers for cardiac fibrosis and heart failure, as well as predictors of cardiovascular events and mortality. However, there are limited data on the association between soluble ST2 and...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society of Nephrology
2021-03-01
|
Series: | Kidney Research and Clinical Practice |
Subjects: | |
Online Access: | http://www.krcp-ksn.org/upload/pdf/j-krcp-20-133.pdf |